Preserving peri-implant health1
Results from a large retrospective study1 of dental implants in a broad clinical setting with 9-year follow-up, showed that the odds ratio of peri-implantitis 9 years after implant therapy was more than three times lower with Straumann® Soft Tissue Level SLA® implants than with Nobel Biocare™ or Astra® Tech Implant System implants.
Odds ratios of peri-implantitis nine years after implant placement1
98.3% Nobel BiocareTM implants with the TiUnite® surface
96.6% Astra® Tech implants with TiOblast® surface
All Straumann® TL implants with SLA® surface
Designed to respect the biological distance
- Implant-abutment interface is moved away from the bone
- No micro-gap in the healing-critical zone
10 years of clinical data – a long history of success
High survival and success rates for the Straumann® Soft Tissue Level Implant System in 10-year retrospective study on partially edentulous patients.2,3
Implant survival rate, 10 years2
Success rate of Straumann secondary prosthetic components, 10 years3,7
Mean of marginal bone loss (in mm) after 10 years
The 10-years prospective clinical data in the edentulous maxilla confirms the high treatment success from both a surgical and restorative perspective of the Soft Tissue Level System.4,6
*according to Albrektsson et al.3
Mean of marginal bone loss after 10 years (in mm)
Straumann® Tissue Level Implant Line Brochure
Find here all relevant information about the Straumann® Tissue Level Implant Line.
For even more details, check the following documents: